keyword
MENU ▼
Read by QxMD icon Read
search

Statins and pancreatitis

keyword
https://www.readbyqxmd.com/read/30465184/statin-treatment-and-outcomes-of-metastatic-pancreatic-cancer-a-pooled-analysis-of-two-phase-iii-studies
#1
O Abdel-Rahman
BACKGROUND: The current analysis aims to evaluate the impact of statin co-treatment on the survival of patients with metastatic pancreatic cancer. METHODS: This is a pooled analysis of de-identified patient data from two clinical trials (NCT01124786; NCT00844649). Overall and progression-free survival according to patient subsets (patients who received or who did not receive statins) were assessed through Kaplan-Meier analysis and log-rank test. Univariate and multivariate Cox regression analysis was performed to evaluate different factors potentially affecting overall and progression-free survival...
November 21, 2018: Clinical & Translational Oncology
https://www.readbyqxmd.com/read/30333217/total-serum-cholesterol-and-pancreatic-cancer-a-nested-case-control-study
#2
William Chang-Yuen Chen, Ben Boursi, Ronac Mamtani, Yu-Xiao Yang
BACKGROUND: Pancreatic cancer is the third leading cause of cancer-related death in the United States. Total serum cholesterol (TSC) may predict cancer risk, though its role independent of statins remains elusive. We examined the association between TSC and pancreatic cancer risk independent of statins. METHODS: A nested case-control analysis was conducted among statin-naïve patients within The Health Improvement Network (THIN), a United Kingdom-based general practice database...
October 17, 2018: Cancer Epidemiology, Biomarkers & Prevention
https://www.readbyqxmd.com/read/30318066/characterizing-familial-chylomicronemia-syndrome-baseline-data-of-the-approach-study
#3
Dirk J Blom, Louis O'Dea, Andres Digenio, Veronica J Alexander, Ewa Karwatowska-Prokopczuk, Karren R Williams, Linda Hemphill, Ovidio Muñiz-Grijalvo, Raul D Santos, Seth Baum, Joseph L Witztum
BACKGROUND: Familial chylomicronemia syndrome (FCS) is a rare metabolic disorder caused by mutations in lipoprotein lipase (LPL) or genes required for LPL functionality and is characterized by hyperchylomicronemia that results in recurrent episodes of acute pancreatitis. Owing to the rarity of FCS, there are few case series describing the phenotypic variability in FCS patients in detail. OBJECTIVE: To provide baseline characteristics in the largest study population to date of patients with FCS...
September 2018: Journal of Clinical Lipidology
https://www.readbyqxmd.com/read/30314951/statin-use-is-associated-to-a-reduced-risk-of-pancreatic-cancer-a-meta-analysis
#4
REVIEW
Livia Archibugi, Paolo Giorgio Arcidiacono, Gabriele Capurso
BACKGROUND: Previous studies investigating the association between statin use and pancreatic cancer (PDAC) risk for a possible chemopreventive effect gathered heterogeneous results. AIMS: To conduct a systematic review and meta-analysis to clarify this association. METHODS: Comprehensive literature search of articles published up to February 2018, including case-control (CC),cohort studies (C), randomized controlled trials (RCTs) assessing association between statin use and PDAC risk...
September 20, 2018: Digestive and Liver Disease
https://www.readbyqxmd.com/read/30290209/metastasis-and-chemoresistance-in-cd133-expressing-pancreatic-cancer-cells-are-dependent-on-their-lipid-raft-integrity
#5
Vineet Kumar Gupta, Nikita S Sharma, Kousik Kesh, Patricia Dauer, Alice Nomura, Bhuwan Giri, Vikas Dudeja, Santanu Banerjee, Sanjoy Bhattacharya, Ashok Saluja, Sulagna Banerjee
Metabolic rewiring is an integral part of tumor growth. Among metabolic pathways, the Mevalonic-Acid-Pathway (MVAP) plays a key role in maintaining membrane architecture through cholesterol synthesis, thereby affecting invasiveness. In the current study, we show for the first time that CD133Hi pancreatic tumor initiating cells (TIC) have increased expression of MVAP enzymes, cholesterol-content and Caveolin expression. Further, we show that CD133 in these cells is localized in the lipid-rafts (characterized by Cav-1-cholesterol association)...
October 2, 2018: Cancer Letters
https://www.readbyqxmd.com/read/30288283/statin-use-is-not-associated-with-an-increased-risk-of-acute-pancreatitis-a-meta-analysis-of-observational-studies
#6
Goran Poropat, Livia Archibugi, Taija Korpela, Karina Cárdenas-Jaén, Enrique de-Madaria, Gabriele Capurso
Background: Statins are perceived as potential etiological factors for acute pancreatitis (AP), but recent evidence suggests the opposite. Our aim was to evaluate the association between statin use and risk of AP in observational studies. Methods: Medline, Scopus, and Web of Science were searched for cohort (C) and case-control (CC) studies evaluating statins as intervention and AP as outcome. Pooled adjusted odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were calculated...
October 2018: United European Gastroenterology Journal
https://www.readbyqxmd.com/read/30265346/type-2-diabetes-in-neuroendocrine-tumors-are-biguanides-and-statins-part-of-the-solution
#7
Aura D Herrera-Martínez, Sergio Pedraza-Arevalo, Fernando L-López, Manuel D Gahete, María A Gálvez-Moreno, Justo P Castaño, Raúl M Luque
Background: Biguanides and statins have been reported to exert beneficial effects on various cancer types. However, their precise effects and underlying molecular mechanisms are still poorly understood. Materials and Methods: We analyzed the relation between metabolic-syndrome, i.e., presence of type-2 diabetes (T2DM), hyperlipidemia and their treatment, with histological, epidemiological, and prognosis variables in two patient cohorts with neuroendocrine-tumors [NETs: lung-carcinoids (LCs; n=81) and gastro-entero-pancreatic (GEP-NET; n=100)]...
September 27, 2018: Journal of Clinical Endocrinology and Metabolism
https://www.readbyqxmd.com/read/30262206/is-hypertriglyceridemia-atherogenic
#8
REVIEW
François Roubille, Ariane Sultan, Fabien Huet, Florence Leclercq, Jean-Christophe Macia, Richard Gervasoni, Delphine Delseny, Mariama Akodad, Camille Roubille
ASCVD reduction is based on LDL reduction, especially by statins. Highly elevated TG could be harmful, especially because of the risk of pancreatitis. Elevation of TG is mainly due to metabolic disorders and diabetes, alcohol intake and overweight. Genetic factors have been clearly identified in the most severe cases. TG have been generally considered as bystanders for cardiovascular diseases (CVD). Both biological and basic research provide strong data suggesting that TG-rich lipoproteins could be involved in the pathophysiology of CVD...
September 2018: La Presse Médicale
https://www.readbyqxmd.com/read/30224317/chronic-use-of-statins-and-risk-of-post-ercp-acute-pancreatitis-stark-study-protocol-for-an-international-multicenter-prospective-cohort-study
#9
Taija Korpela, Karina Cárdenas-Jaén, Livia Archibugi, Goran Poropat, Patrick Maisonneuve, Paolo Giorgio Arcidiacono, Nicolò De Pretis, Matthias Löhr, Gabriele Capurso, Enrique de-Madaria
BACKGROUND: Acute pancreatitis (AP) is the most common complication after endoscopic retrograde cholangiopancreatography (ERCP). Statins have been traditionally associated to an increased risk of AP, however, recent evidence suggests that statins may have a protective role against this disease. AIMS: Our primary aim is to investigate whether the use of statins has a protective effect against post-ERCP pancreatitis (PEP). Secondary outcomes are: to evaluate the effect of other drugs on the incidence of PEP; to ascertain the relationship between the use of statins and the severity of PEP; and to evaluate the effect of other risk and protective factors on the incidence of PEP...
August 20, 2018: Digestive and Liver Disease
https://www.readbyqxmd.com/read/30126762/the-clinical-importance-of-recognizing-capecitabine-induced-hypertriglyceridemia-a-case-report-and-review-of-the-literature
#10
Jenny Leung, Jessica Louise Brady, Martin Andrew Crook
This case report describes a patient who developed a mixed hyperlipidemia and severe hypertriglyceridemia (>20 mmol/L or 1772 mg/dL) while receiving capecitabine chemotherapy. After lipid-lowering treatment (statin and omega-3 acid ethyl esters) and completion of chemotherapy, her lipid levels had been significantly reduced. Other secondary causes of hyperlipidemia were also investigated. In view of the abnormal lipid results worsened by capecitabine, we suggest that careful lipid monitoring and thorough lipid management are important in such patients to avoid acute pancreatitis...
July 25, 2018: Journal of Clinical Lipidology
https://www.readbyqxmd.com/read/30053075/re-influence-of-statins-and-cholesterol-on-mortality-among-patients-with-pancreatic-cancer
#11
Muyun Liu, Hongbo Jiang, Yaying Yang, Zhaoshen Li, Weiqin Lu
No abstract text is available yet for this article.
December 1, 2017: Journal of the National Cancer Institute
https://www.readbyqxmd.com/read/30034255/evidence-based-complementary-treatment-of-pancreatic-cancer-a-review-of-adjunct-therapies-including-paricalcitol-hydroxychloroquine-intravenous-vitamin-c-statins-metformin-curcumin-and-aspirin
#12
REVIEW
Stephen Bigelsen
Despite new and exciting research and renewed optimism about future therapy, current statistics of survival from pancreatic cancer remains dismal. Patients seeking alternative or complementary treatments should be warned to avoid the hype and instead look to real science. A variety of relatively safe and inexpensive treatment options that have shown success in preclinical models and/or retrospective studies are currently available. Patients require their physicians to provide therapeutic guidance and assistance in obtaining and administrating these various therapies...
2018: Cancer Management and Research
https://www.readbyqxmd.com/read/30015940/short%C3%A2-term-use-of-atorvastatin-affects-glucose-homeostasis-and-suppresses-the-expression-of-ldl-receptors-in-the-pancreas-of-mice
#13
Qi Yu, Fang Wang, Xiaodong Meng, Yiren Gong, Yanli Wang, Cangbao Xu, Siwang Wang
Low‑density lipoprotein receptors (LDLRs) may serve a role in the diabetogenic effect of statins; however, the effects of statins on LDLR expression and its regulation in the pancreas and islets have yet to be determined. To exclude the long‑term effects of treatment with atorvastatin, which allows mice to adapt, male C57BL/j and apolipoprotein E‑deficient mice were acutely treated with oral atorvastatin for 6 weeks, and glucose homeostasis and LDLR expression in the pancreas and islets were examined...
September 2018: Molecular Medicine Reports
https://www.readbyqxmd.com/read/30008671/chronic-use-of-statins-and-their-effect-on-prevention-of-post-endoscopic-retrograde-cholangiopancreatography-pancreatitis
#14
Mahmud Mahamid, Abdulla Watad, Nicola L Bragazzi, Dov Wengrower, Julie Wolff, Dan Livovsky, Howard Amital, Mohammad Adawi, Eran Goldin
Background and Aims: Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is one of the major complications of ERCP. Thus, several non-invasive as well as invasive strategies have been investigated as preventative therapies for PEP with various efficacy. Methods: We enrolled any patients who underwent ERCP both at the Shaare Zedek Medical Center in Jerusalem and EMMS Nazareth hospital. Association between use of statins and different variables were assessed with univariate tests (chi-squared for categorical variables)...
2018: Frontiers in Pharmacology
https://www.readbyqxmd.com/read/29904289/identifying-suspected-familial-chylomicronemia-syndrome
#15
Ronak Rengarajan, Peter A McCullough, Anima Chowdhury, Kristen M Tecson
Familial chylomicronemia syndrome (FCS) is a rare lipid disorder posing significant clinical burdens on patients. Due to its rarity, variety of presentations, and lack of universal diagnostic criteria, patients see an average of five physicians before diagnosis. We screened adults for a triglyceride level ≥1000 mg/dL from September 2015 to September 2016 and a history of pancreatitis and performed a thorough chart review on those who met the criteria. An adjudication panel used a definition that also called for supportive information including history of hypertriglyceridemia or family history of pancreatitis/hypertriglyceridemia...
July 2018: Proceedings of the Baylor University Medical Center
https://www.readbyqxmd.com/read/29842811/pharmacological-treatment-options-for-severe-hypertriglyceridemia-and-familial-chylomicronemia-syndrome
#16
REVIEW
Rabia Chaudhry, Adie Viljoen, Anthony S Wierzbicki
A spectrum of disorders, ranging from rare severe cases of homozygous null lipoprotein lipase deficiency (LPLD)-familial chylomicronemia syndrome (FCS) to heterozygous missense LPLD or polygenic causes, result in hypertriglyceridemia and pancreatitis. The effects of mutations are exacerbated by environmental factors such as diet, pregnancy, and insulin resistance. Areas covered: In this review, authors discuss chronic treatment of FCS by ultra-low fat diets allied with the use of fibrates, omega-3 fatty acids, niacin, statins, and insulin-sensitizing therapies depending on the extent of residual lipoprotein lipase (LPL) activity; novel therapies in development target triglyceride (TG)-rich lipoprotein particle clearance...
June 2018: Expert Review of Clinical Pharmacology
https://www.readbyqxmd.com/read/29697526/chronic-pancreatitis-progression-in-the-use-of-statins
#17
LETTER
Lu Hao, Zhao-Shen Li, Liang-Hao Hu
No abstract text is available yet for this article.
June 2018: European Journal of Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/29627496/simvastatin-inhibits-sonic-hedgehog-signaling-and-stemness-features-of-pancreatic-cancer
#18
Yefeng Yin, Li Liu, Zhefu Zhao, Libo Yin, Nathalie Bauer, Clifford C Nwaeburu, Jury Gladkich, Wolfgang Gross, Thilo Hackert, Carsten Sticht, Norbert Gretz, Oliver Strobel, Ingrid Herr
Pancreatic ductal adenocarcinoma (PDA) has poor therapeutic options. Recent patient studies indicate that cholesterol-lowering statins have anti-tumor capacities. We examined several established and primary PDA and normal cell lines as well as PDA patient tissues (n = 68). We found that simvastatin inhibited viability, stemness, tumor growth and metastasis and that it enhanced the efficacy of gemcitabine. These changes were associated with modulation of Shh-related gene expression. Overexpression of Shh prevented the anti-cancer effect of simvastatin, and inhibition of Shh mimicked the simvastatin effect...
July 10, 2018: Cancer Letters
https://www.readbyqxmd.com/read/29587290/chemoprevention-and-treatment-of-pancreatic-cancer-update-and-review-of-the-literature
#19
REVIEW
Julia Benzel, Volker Fendrich
BACKGROUND: Pancreatic ductal adenocarcinoma is one of the most lethal types of cancer with a 5-year survival rate of around 7%. Due to the relatively poor prognosis, the potential need of an effective chemoprevention is highly needed. SUMMARY: Different risk factors like smoking or hereditary tumour syndromes should be known for early detection of pancreatic intraepithelial neoplasia. Chemopreventive dietary agents include curcumin, capsaicin and flavonoid, whereas potential chemopreventive drugs compromise aspirin, metformin or statins...
2018: Digestion
https://www.readbyqxmd.com/read/29509593/targeting-tumor-metabolism-with-statins-during-treatment-for-advanced-stage-pancreatic-cancer
#20
Nick A Iarrobino, Beant Gill, Mark E Bernard, Mark V Mishra, Colin E Champ
INTRODUCTION: A growing body of preclinical data suggests that statins may exert potent antitumor effects, yet the interactions of these medications with standard therapies and clinical outcomes in this population is less clear. We assessed the impact of statin use on outcomes in patients with advanced-stage pancreatic adenocarcinoma undergoing various treatments. MATERIALS AND METHODS: After institutional review board approval, we conducted a retrospective-cohort study consisting of 303 newly diagnosed advanced-stage pancreatic adenocarcinoma patients to determine the impact of statin use on outcomes...
March 5, 2018: American Journal of Clinical Oncology
keyword
keyword
165208
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"